GlassScriptPhysician profile
Ron Israeli
NPI 1396777025
$35,470.10
in general payments reported to CMS, 2019-2025
13 companies · $1,470 in 2025
The $1,470 reported for 2025 was more than what 80% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $9,204 · 2021: $87.15 · 2022: $205 · 2023: $106 · 2024: $252 · 2025: $1,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,200 · Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,200.00 |
| Food and Beverage | $628.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $33,103.59 | 2019-2020 | |
| Rti Surgical, INC | $1,222.88 | 2023-2025 | |
| Mentor Worldwide LLC | $318.45 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Allergan, INC. | $296.35 | 2019-2022 | |
| Abbvie INC. | $225.65 | 2023-2025 | |
| Axogen | $109.40 | 2022-2025 | |
| Heron Therapeutics, INC. | $33.44 | 2025 | Aponvie |
| Solventum Corporation | $30.98 | 2024 | Prevena, V.A.C.Ulta, Prevena Restor Bellaform |
| Aroa Biosurgery Incorporated | $27.61 | 2025 | |
| Sientra, INC. | $27.18 | 2021 | |
| Kci USA, INC. | $27.06 | 2020 | |
| Integra Lifesciences Corporation | $24.10 | 2020 | |
| Baxter Healthcare | $23.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Israeli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.